INTRODUCTION
Atypical subtrochanteric or femoral shaft fractures occasionally show delayed union, especially in osteoporosis patients undergoing long-term treatment with bisphosphonates.
However, there have been few published studies on the effects of pharmacotherapy on Electronic supplementary material The online version of this article (doi:10.1007/s13554-014-0013-5) contains supplementary material, which is available to authorized users. these fractures. Previous studies have suggested that teriparatide (TPTD) therapy can be effective to promote healing of fractures with delayed unions [1] [2] [3] [4] [5] [6] . However, it is still unknown whether a once-weekly administration of TPTD could offer an effective alternative to the daily TPTD. Herein, the authors report a patient with delayed union after surgery for an atypical femoral fracture (AFF) who was effectively treated with once-weekly administration of 56.5 lg of TPTD.
CASE REPORT
A 74-year-old female patient with osteoporosis, who had been taking alendronate and alfacalcidol for approximately 6 years, suffered femur fractures following a fall in March 2012. Radiography revealed a subtrochanteric right femur fracture (Fig. 1a) . In addition, her contralateral thigh showed thickening of the lateral cortex and a transverse radiolucent fracture line in the subtrochanter (Fig. 1b) . The patient was diagnosed with AFFs. The patient had normal levels of bone resorption markers, but low levels of a bone formation marker (Table 1) .
Four days after admission, the authors performed minimally invasive osteosynthesis using intramedullary nails (Fig. 2) . Alfacalcidol was continued but alendronate was ceased. Two weeks later, low-intensity pulsed ultrasonography (LIPUS) therapy was started for both thigh regions to promote bone healing. In June 2012, radiography and computed tomography imaging revealed signs of delayed union at the right fracture site (Fig. 3) .
The patient could not walk without a crutch owing to contralateral thigh pain. After obtaining informed consent, prophylactic osteosynthesis was performed on the left subtrochanteric lesion in June 2012. Bone biopsy samples collected at the intramedullary nail insertion site revealed an absence of osteoblasts and osteoclasts on trabecular surfaces (Fig. 4) , as well as low bone volume ( Table 2) . LIPUS treatment was restarted after surgery.
In August 2012, once-weekly TPTD (56.5 lg) was added, and the patient's tartrate-resistant acid phosphatase type 5b (TRACP-5b) and procollagen type 1N-terminal propeptide (P1NP) levels increased transiently, as did their lumbar bone mineral density (Table 3) . After 3 months of TPTD treatment, the patient's fractures had improved (Fig. 5) . Administration of TPTD was terminated in February 2013 and Union of both femur fractures was confirmed after 3 months of TPTD treatment. It was 
